Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer.
about
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.An imaging agent to detect androgen receptor and its active splice variants in prostate cancerSintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.Non-Genomic Actions of the Androgen Receptor in Prostate CancerAndrogen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate Cancer.Prostate cancer health disparities: An immuno-biological perspective.Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer.[Inhibitors of the androgen receptor N‑terminal domain : Therapies targeting the Achilles' heel of various androgen receptor molecules in advanced prostate cancer].Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens.Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
P2860
Q33761920-C1C0D133-B2E5-402C-8AB3-195A0DAE20B5Q36312095-7F574081-EE5D-4154-BC46-78CAF03E9B1BQ37165574-EB8A68AD-07F8-42BD-A924-02F627E6F8F3Q37338900-2CFD10C2-A20E-4E47-9040-D07B9F59D0B4Q37496652-CB53BD6A-0810-4251-8478-5D68981F5877Q37588620-91B4BC7A-DCFE-4E06-AEE9-95D9D5DC25BEQ37709535-22B86C4C-0E41-45BB-8FA9-7CF5EF4FD174Q42125180-8BF3312C-51CA-415A-9E51-6E8256FD87BEQ46537204-C99CA922-0BFA-4D3B-8860-544AC06C8513Q47109527-24E5CABB-CCE1-47C9-8087-4BECC375D707Q49940352-67186BC8-5DF2-4B63-ACDB-54AA38FE81D0Q52677958-60938CE6-E292-4FCA-9060-DA3DA0CDCA8DQ53735518-6D881150-16A4-48E9-A9B2-213132072084Q54111821-E589BD71-C64F-4B9E-A3AA-06AFAF311306Q58698705-5A291CCF-16D6-4E9C-851A-7C66D9307EC2
P2860
Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting Androgen Receptor Ac ...... ion-Resistant Prostate Cancer.
@en
type
label
Targeting Androgen Receptor Ac ...... ion-Resistant Prostate Cancer.
@en
prefLabel
Targeting Androgen Receptor Ac ...... ion-Resistant Prostate Cancer.
@en
P2093
P2860
P50
P1476
Targeting Androgen Receptor Ac ...... ion-Resistant Prostate Cancer.
@en
P2093
Carmen Adriana Banuelos
Iain J McEwan
Minoru Kato
Nasrin R Mawji
Stephen Plymate
P2860
P304
P356
10.1158/1078-0432.CCR-15-2901
P407
P577
2016-05-02T00:00:00Z